Search Results

Conventus Flower Orthopedics, an innovation-driven medical technology company, announced the appointment of Anjan R. Shah, MD as its Chief Medical Officer.

Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Food and Drug Administration 510 clearance for the Flex-Thread™ Ulna Intramedullary Nail System.

Conventus Flower Orthopedics announced that Brad Niemann has been appointed as the Company’s Chief Executive Officer, effective immediately.

Watertown Regional Medical Center and Healthcare Outcomes Performance Company have joined forces to provide top-tier orthopedic and spine care for patients.

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced that it will enter into a new Collaboration Agreement with Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company.

Stratasys Ltd. and Ricoh USA, Inc. announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.

The Orthopedic Partners, a leading orthopedic care provider based in Utah, announced the expansion of its services to include pediatric orthopedic care with the addition of John Heflin, M.D., John Smith, M.D. and Marcella Woiczik, M.D., to its team of esteemed orthopedic physicians.

Ricoh USA, Inc. and Stratasys Ltd. (NASDAQ: SSYS) today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.

Conventus-Flower Orthopedics, a medical device company focused on optimizing patient care by pioneering innovative solutions that address complex orthopedic challenges to streamline surgery, announced a partnership with Red One Medical, a private sector scout of medical innovation for the Department of Veterans Affairs and Department of Defense.

ZKR Orthopedics, Inc. announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for a multicenter prospective clinical trial.